Madison, WI. February 15th, 2017.


Cellular Logistics is pleased to announce closing on a financing round from friends and family. Funds will be used to further development of cardiac therapeutics based on the Company’s patented biomaterial. CEO Rick Soni stated: “We are excited to move forward with pre-clinical and commercialization activities. The funding represents a statement of confidence and excitement for the long-term potential of the Company’s technologies and products.”



About the Company: Cellular Logistics is an early stage life science venture based on research at The Wisconsin Institute for Medical Research (WIMR) at the University of Wisconsin-Madison. The Company is commercializing an acellular biomaterial as a stand-alone therapeutic for cardiac and tissue vascularization applications. The material also provides a cell delivery mechanism for regenerative medicine therapeutics.